{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:34Z","timestamp":1787023714051,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10067-026-08189-6","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:01:03Z","timestamp":1780153263000},"page":"4735-4745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming of the lipid metabolism axis in systemic sclerosis: mechanism analysis and therapeutic potential"],"prefix":"10.1007","volume":"45","author":[{"given":"Rong-hong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9798-1269","authenticated-orcid":false,"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"10373","key":"8189_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andreasson K, Smith V (2023) Systemic sclerosis. Lancet 401(10373):304\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(22)01692-0","journal-title":"Lancet"},{"issue":"6","key":"8189_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.7861\/clinmed.2020-0754","volume":"20","author":"A Haque","year":"2020","unstructured":"Haque A, Hughes M (2020) Raynaud\u2019s phenomenon. Clin Med (Lond) 20(6):580\u2013587. https:\/\/doi.org\/10.7861\/clinmed.2020-0754","journal-title":"Clin Med (Lond)"},{"issue":"8","key":"8189_CR3","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1093\/rheumatology\/keac049","volume":"61","author":"A Lescoat","year":"2022","unstructured":"Lescoat A, Sandler RD, Zimmermann F, Roofeh D, Hughes M, Pauling JD et al (2022) Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review. Rheumatology (Oxford) 61(8):3132\u20133148. https:\/\/doi.org\/10.1093\/rheumatology\/keac049","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8189_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/rheumatology\/kex504","volume":"57","author":"O Distler","year":"2018","unstructured":"Distler O, Allanore Y, Denton CP, Matucci-Cerinic M, Pope JE, Hinzmann B et al (2018) Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 57(5):813\u2013817. https:\/\/doi.org\/10.1093\/rheumatology\/kex504","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8189_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51(6):1017\u20131026. https:\/\/doi.org\/10.1093\/rheumatology\/ker269","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"8189_CR6","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.7150\/thno.41388","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Feng Z, He ML (2020) Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics 10(16):7053\u20137069. https:\/\/doi.org\/10.7150\/thno.41388","journal-title":"Theranostics"},{"issue":"6","key":"8189_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.5114\/aoms.2019.89451","volume":"15","author":"H Mysliwiec","year":"2019","unstructured":"Mysliwiec H, Harasim-Symbor E, Baran A, Szterling-Jaworowska M, Milewska AJ, Chabowski A et al (2019) Abnormal serum fatty acid profile in psoriatic arthritis. Arch Med Sci 15(6):1407\u20131414. https:\/\/doi.org\/10.5114\/aoms.2019.89451","journal-title":"Arch Med Sci"},{"key":"8189_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00822","volume":"11","author":"A Ottria","year":"2020","unstructured":"Ottria A, Hoekstra AT, Zimmermann M, van der Kroef M, Vazirpanah N, Cossu M et al (2020) Fatty acid and carnitine metabolism are dysregulated in systemic sclerosis patients. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00822","journal-title":"Front Immunol"},{"issue":"6","key":"8189_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/BOR.0000000000000437","volume":"29","author":"RG Marangoni","year":"2017","unstructured":"Marangoni RG, Lu TT (2017) The roles of dermal white adipose tissue loss in scleroderma skin fibrosis. Curr Opin Rheumatol 29(6):585\u2013590. https:\/\/doi.org\/10.1097\/BOR.0000000000000437","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"8189_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/ar4285","volume":"15","author":"O Timar","year":"2013","unstructured":"Timar O, Szekanecz Z, Kerekes G, Vegh J, Olah AV, Nagy G et al (2013) Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis- -a prospective case-series study. Arthritis Res Ther 15(5). https:\/\/doi.org\/10.1186\/ar4285","journal-title":"Arthritis Res Ther"},{"key":"8189_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2017.12.003","author":"RA DeBose-Boyd","year":"2018","unstructured":"DeBose-Boyd RA (2018) Significance and regulation of lipid metabolism. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2017.12.003","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"8189_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbalip.2006.06.003","volume":"1761","author":"J Oestvang","year":"2006","unstructured":"Oestvang J, Johansen B (2006) PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis. Biochim Biophys Acta 1761(11):1309\u20131316. https:\/\/doi.org\/10.1016\/j.bbalip.2006.06.003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"8189_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","volume":"17","author":"CW Ko","year":"2020","unstructured":"Ko CW, Qu J, Black DD, Tso P (2020) Regulation of intestinal lipid metabolism: current concepts and relevance to disease. Nat Rev Gastroenterol Hepatol 17(3):169\u2013183. https:\/\/doi.org\/10.1038\/s41575-019-0250-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"8189_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","volume":"64","author":"HK Park","year":"2015","unstructured":"Park HK, Ahima RS (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64(1):24\u201334. https:\/\/doi.org\/10.1016\/j.metabol.2014.08.004","journal-title":"Metabolism"},{"issue":"9","key":"8189_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1507\/endocrj.EJ25-0180","volume":"72","author":"A Ito","year":"2025","unstructured":"Ito A (2025) Lipid metabolic reprogramming in immune regulation and chronic inflammatory diseases. Endocr J 72(9):979\u2013985. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0180","journal-title":"Endocr J"},{"issue":"9","key":"8189_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411911","volume":"12","author":"C Deng","year":"2025","unstructured":"Deng C, Xiao Y, Zhao X, Li H, Chen Y, Ai K et al (2025) Sequential targeting chondroitin sulfate\u2010bilirubin nanomedicine attenuates osteoarthritis via reprogramming lipid metabolism in M1 macrophages. Adv Sci 12(9). https:\/\/doi.org\/10.1002\/advs.202411911","journal-title":"Adv Sci"},{"issue":"7","key":"8189_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/rheumatology\/kel012","volume":"45","author":"F Ogawa","year":"2006","unstructured":"Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K et al (2006) Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology (Oxford) 45(7):815\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kel012","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"8189_CR18","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1111\/bph.15190","volume":"177","author":"L Ledein","year":"2020","unstructured":"Ledein L, Leger B, Dees C, Beyer C, Distler A, Vettori S et al (2020) Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse. Br J Pharmacol 177(18):4296\u20134309. https:\/\/doi.org\/10.1111\/bph.15190","journal-title":"Br J Pharmacol"},{"key":"8189_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20186721","author":"P Vinci","year":"2023","unstructured":"Vinci P, Di Girolamo FG, Panizon E, Tosoni LM, Cerrato C, Pellicori F et al (2023) Lipoprotein(a) as a risk factor for cardiovascular diseases: pathophysiology and treatment perspectives. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph20186721","journal-title":"Int J Environ Res Public Health"},{"key":"8189_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1196\/annals.1422.028","volume":"1108","author":"Y Sherer","year":"2007","unstructured":"Sherer Y, Cerinic MM, Bartoli F, Blagojevic J, Conforti ML, Gilburd B et al (2007) Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 1108:259\u201367. https:\/\/doi.org\/10.1196\/annals.1422.028","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"8189_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","volume":"25","author":"EF Borba","year":"2005","unstructured":"Borba EF, Borges CT, Bonfa E (2005) Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 25(5):379\u2013383. https:\/\/doi.org\/10.1007\/s00296-004-0580-8","journal-title":"Rheumatol Int"},{"issue":"3","key":"8189_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/03009742.2020.1837237","volume":"50","author":"HB Kim","year":"2021","unstructured":"Kim HB, Kim A, Kim Y, Kim GT, Ahn E, So MW et al (2021) Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis. Scand J Rheumatol 50(3):231\u2013238. https:\/\/doi.org\/10.1080\/03009742.2020.1837237","journal-title":"Scand J Rheumatol"},{"key":"8189_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/ar1790","author":"VS Rajkumar","year":"2005","unstructured":"Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ (2005) Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/ar1790","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8189_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/ard-2022-223237","volume":"82","author":"S Sanges","year":"2023","unstructured":"Sanges S, Rice L, Tu L, Valenzi E, Cracowski J-L, Montani D et al (2023) Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis. Ann Rheum Dis 82(3):365\u2013373. https:\/\/doi.org\/10.1136\/ard-2022-223237","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8189_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00403-019-01893-1","volume":"311","author":"J Zolkiewicz","year":"2019","unstructured":"Zolkiewicz J, Stochmal A, Rudnicka L (2019) The role of adipokines in systemic sclerosis: a missing link? Arch Dermatol Res 311(4):251\u2013263. https:\/\/doi.org\/10.1007\/s00403-019-01893-1","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"8189_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjd.13779","volume":"173","author":"T Takahashi","year":"2015","unstructured":"Takahashi T, Asano Y, Noda S, Aozasa N, Akamata K, Taniguchi T et al (2015) A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. Br J Dermatol 173(3):681\u20139. https:\/\/doi.org\/10.1111\/bjd.13779","journal-title":"Br J Dermatol"},{"issue":"3","key":"8189_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10238-021-00756-2","volume":"22","author":"C Pellicano","year":"2022","unstructured":"Pellicano C, Leodori G, Colalillo A, Navarini L, Gigante A, Rosato E (2022) Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis. Clin Exp Med 22(3):421\u2013426. https:\/\/doi.org\/10.1007\/s10238-021-00756-2","journal-title":"Clin Exp Med"},{"key":"8189_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpba.2018.09.021","volume":"162","author":"A Fernandez-Ochoa","year":"2019","unstructured":"Fernandez-Ochoa A, Quirantes-Pine R, Borras-Linares I, Gemperline D, Consortium P C, Alarcon Riquelme ME et al (2019) Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients. J Pharm Biomed Anal 162:82\u201390. https:\/\/doi.org\/10.1016\/j.jpba.2018.09.021","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"8189_CR29","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1172\/JCI85740","volume":"126","author":"JJ Chia","year":"2016","unstructured":"Chia JJ, Zhu T, Chyou S, Dasoveanu DC, Carballo C, Tian S et al (2016) Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis. J Clin Invest 126(11):4331\u20134345. https:\/\/doi.org\/10.1172\/JCI85740","journal-title":"J Clin Invest"},{"issue":"13","key":"8189_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87146","volume":"1","author":"I Kasza","year":"2016","unstructured":"Kasza I, Hernando D, Roldan-Alzate A, Alexander CM, Reeder SB (2016) Thermogenic profiling using magnetic resonance imaging of dermal and other adipose tissues. JCI Insight 1(13). https:\/\/doi.org\/10.1172\/jci.insight.87146","journal-title":"JCI Insight"},{"issue":"8","key":"8189_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084095","volume":"22","author":"N Brezovec","year":"2021","unstructured":"Brezovec N, Perdan-Pirkmajer K, Cucnik S, Sodin-Semrl S, Varga J, Lakota K (2021) Adiponectin deregulation in systemic autoimmune rheumatic diseases. Int J Mol Sci 22(8)","journal-title":"Int J Mol Sci"},{"issue":"10","key":"8189_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/art.40533","volume":"70","author":"Y Yokoyama","year":"2018","unstructured":"Yokoyama Y, Sekiguchi A, Fujiwara C, Uchiyama A, Uehara A, Ogino S et al (2018) Inhibitory regulation of skin fibrosis in systemic sclerosis by Apelin\/APJ signaling. Arthritis Rheumatol 70(10):1661\u20131672. https:\/\/doi.org\/10.1002\/art.40533","journal-title":"Arthritis Rheumatol"},{"key":"8189_CR33","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S18145","author":"PD Postlethwaite","year":"2011","unstructured":"Postlethwaite PD, Brown M (2011) Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res. https:\/\/doi.org\/10.2147\/jir.S18145","journal-title":"J Inflamm Res"},{"issue":"3","key":"8189_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","volume":"37","author":"G Boden","year":"2008","unstructured":"Boden G (2008) Obesity and free fatty acids. Endocrinol Metab Clin North Am 37(3):635\u2013646. https:\/\/doi.org\/10.1016\/j.ecl.2008.06.007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"8189_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031308","volume":"23","author":"S Kotlyarov","year":"2022","unstructured":"Kotlyarov S, Kotlyarova A (2022) Involvement of fatty acids and their metabolites in the development of inflammation in atherosclerosis. Int J Mol Sci 23(3)","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8189_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2703105","volume":"27","author":"A Shaito","year":"2022","unstructured":"Shaito A, Aramouni K, Assaf R, Parenti A, Orekhov A, Yazbi AE et al (2022) Oxidative stress-induced endothelial dysfunction in cardiovascular diseases. Front Biosci (Landmark Ed) 27(3). https:\/\/doi.org\/10.31083\/j.fbl2703105","journal-title":"Front Biosci (Landmark Ed)"},{"key":"8189_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8848161","volume":"2021","author":"AH Mariamenatu","year":"2021","unstructured":"Mariamenatu AH, Abdu EM (2021) Overconsumption of Omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of Omega-3 PUFAs in modern-day diets: the disturbing factor for their \u201cbalanced antagonistic metabolic functions\u201d in the human body. J Lipids 2021. https:\/\/doi.org\/10.1155\/2021\/8848161","journal-title":"J Lipids"},{"issue":"1","key":"8189_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0514-6","volume":"16","author":"K Yamagata","year":"2017","unstructured":"Yamagata K (2017) Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. Lipids Health Dis 16(1). https:\/\/doi.org\/10.1186\/s12944-017-0514-6","journal-title":"Lipids Health Dis"},{"issue":"7","key":"8189_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069415","volume":"8","author":"A Ishikado","year":"2013","unstructured":"Ishikado A, Morino K, Nishio Y, Nakagawa F, Mukose A, Sono Y et al (2013) 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PLoS One 8(7). https:\/\/doi.org\/10.1371\/journal.pone.0069415","journal-title":"PLoS One"},{"key":"8189_CR40","unstructured":"The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC\u03b5 inhibition."},{"key":"8189_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbrc.2022.07.036","volume":"623","author":"A Tomar","year":"2022","unstructured":"Tomar A, Sahoo S, Aathi M, Kuila S, Khan MA, Ravi GRR et al (2022) Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis. Biochem Biophys Res Commun 623:59\u201365. https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.036","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"8189_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Murugesan P, Huang K, Cai H (2020) NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol 17(3):170\u2013194. https:\/\/doi.org\/10.1038\/s41569-019-0260-8","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"8189_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr., Ansell BJ, Barter P, Chapman MJ, Heinecke JW et al (2016) Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13(1):48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"8189_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14341\/probl12827","volume":"67","author":"SS Shklyaev","year":"2021","unstructured":"Shklyaev SS, Melnichenko GA, Volevodz NN, Falaleeva NA, Ivanov SA, Kaprin AD et al (2021) Adiponectin: a pleiotropic hormone with multifaceted roles. Probl Endokrinol (Mosk) 67(6):98\u2013112. https:\/\/doi.org\/10.14341\/probl12827","journal-title":"Probl Endokrinol (Mosk)"},{"issue":"7","key":"8189_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/ATVBAHA.112.250142","volume":"32","author":"EK Anderson","year":"2012","unstructured":"Anderson EK, Hill AA, Hasty AH (2012) Stearic acid accumulation in macrophages induces toll-like receptor 4\/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis. Arterioscler Thromb Vasc Biol 32(7):1687\u20131695. https:\/\/doi.org\/10.1161\/ATVBAHA.112.250142","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"8189_CR46","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.4049\/jimmunol.2300293","volume":"211","author":"KKY Ting","year":"2023","unstructured":"Ting KKY, Yu P, Dow R, Floro E, Ibrahim H, Scipione CA et al (2023) Oxidized low-density lipoprotein accumulation suppresses glycolysis and attenuates the macrophage inflammatory response by diverting transcription from the HIF-1\u03b1 to the Nrf2 pathway. J Immunol 211(10):1561\u20131577. https:\/\/doi.org\/10.4049\/jimmunol.2300293","journal-title":"J Immunol"},{"key":"8189_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0241-4","volume":"15","author":"B Allam-Ndoul","year":"2016","unstructured":"Allam-Ndoul B, Guenard F, Barbier O, Vohl MC (2016) Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages. Lipids Health Dis 15. https:\/\/doi.org\/10.1186\/s12944-016-0241-4","journal-title":"Lipids Health Dis"},{"issue":"1","key":"8189_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-024-03379-6","volume":"26","author":"N Kortam","year":"2024","unstructured":"Kortam N, Liang W, Shiple C, Huang S, Gedert R, Clair JS et al (2024) Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog. Arthritis Res Ther 26(1):139. https:\/\/doi.org\/10.1186\/s13075-024-03379-6","journal-title":"Arthritis Res Ther"},{"key":"8189_CR49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221085","volume":"219","author":"K Gordon","year":"2022","unstructured":"Gordon K, Cubillos-Ruiz JR, Barrat FJ (2022) Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses. J Exp Med 219. https:\/\/doi.org\/10.1084\/jem.20221085","journal-title":"J Exp Med"},{"issue":"26","key":"8189_CR50","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","volume":"136","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Lam PY, Jiang H, Bednarska K, Gloury R, Murigneux V et al (2020) Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136(26):3004\u20133017. https:\/\/doi.org\/10.1182\/blood.2020005602","journal-title":"Blood"},{"issue":"11","key":"8189_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103185","volume":"21","author":"W Jin","year":"2022","unstructured":"Jin W, Zheng Y, Zhu P (2022) T cell abnormalities in systemic sclerosis. Autoimmun Rev 21(11)","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8189_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cei\/uxae032","volume":"217","author":"L Martin-Gutierrez","year":"2024","unstructured":"Martin-Gutierrez L, Waddington KE, Maggio A, Coelewij L, Oppong AE, Yang N et al (2024) Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosis. Clin Exp Immunol 217(2):204\u2013218. https:\/\/doi.org\/10.1093\/cei\/uxae032","journal-title":"Clin Exp Immunol"},{"key":"8189_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","volume":"14","author":"XF Liu","year":"2023","unstructured":"Liu XF, Shao JH, Liao YT, Wang LN, Jia Y, Dong PJ et al (2023) Regulation of short-chain fatty acids in the immune system. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1186892","journal-title":"Front Immunol"},{"issue":"7","key":"8189_CR54","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.celrep.2019.07.044","volume":"28","author":"P Chakraborty","year":"2019","unstructured":"Chakraborty P, Vaena SG, Thyagarajan K, Chatterjee S, Al-Khami A, Selvam SP et al (2019) Pro-survival lipid sphingosine-1-phosphate metabolically programs T cells to limit anti-tumor activity. Cell Rep 28(7):1879-1893 e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.044","journal-title":"Cell Rep"},{"key":"8189_CR55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003976","author":"J Frostegard","year":"2016","unstructured":"Frostegard J, Zhang Y, Sun J, Yan K, Liu A (2016) Oxidized low-density lipoprotein (OxLDL)-treated dendritic cells promote activation of T cells in human atherosclerotic plaque and blood, which is repressed by statins: microRNA let-7c is integral to the effect. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.003976","journal-title":"J Am Heart Assoc"},{"key":"8189_CR56","doi-asserted-by":"publisher","unstructured":"Sofi M H, Heinrichs J, Dany M, Nguyen H, Dai M, Bastian D, et al. (2017) Ceramide synthesis regulates T cell activity and GVHD development. JCI Insight.2(10):https:\/\/doi.org\/10.1172\/jci.insight.91701","DOI":"10.1172\/jci.insight.91701"},{"key":"8189_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1232820","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Zhao M, Luo W, Huang J, Zhao B, Zhou Z (2023) B cell metabolism in autoimmune diseases: signaling pathways and interventions. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1232820","journal-title":"Front Immunol"},{"issue":"5","key":"8189_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104209","volume":"25","author":"H Tang","year":"2022","unstructured":"Tang H, Li Y, Wang S, Ji J, Zhu X, Bao Y et al (2022) IP(3)R-mediated Ca(2+) signaling controls B cell proliferation through metabolic reprogramming. iScience 25(5). https:\/\/doi.org\/10.1016\/j.isci.2022.104209","journal-title":"iScience"},{"key":"8189_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100375","author":"M Neighbors","year":"2023","unstructured":"Neighbors M, Li Q, Zhu S, Liu J, Wong WR, Jia G et al (2023) Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis. J Lipid Res. https:\/\/doi.org\/10.1016\/j.jlr.2023.100375","journal-title":"J Lipid Res"},{"issue":"7","key":"8189_CR60","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung YC, Stoddard NC, Chun J (2014) LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res 55(7):1192\u20131214. https:\/\/doi.org\/10.1194\/jlr.R046458","journal-title":"J Lipid Res"},{"issue":"3","key":"8189_CR61","doi-asserted-by":"publisher","first-page":"L355","DOI":"10.1152\/ajplung.00039.2022","volume":"323","author":"MH Lee","year":"2022","unstructured":"Lee MH, Sanders L, Kumar R, Hernandez-Saavedra D, Yun X, Ford JA et al (2022) Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 323(3):L355\u2013L371. https:\/\/doi.org\/10.1152\/ajplung.00039.2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"8189_CR62","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","volume":"26","author":"AJ Kattoor","year":"2019","unstructured":"Kattoor AJ, Kanuri SH, Mehta JL (2019) Role of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem 26(9):1693\u20131700. https:\/\/doi.org\/10.2174\/0929867325666180508100950","journal-title":"Curr Med Chem"},{"issue":"2","key":"8189_CR63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","volume":"21","author":"E El Agha","year":"2017","unstructured":"El Agha E, Kramann R, Schneider RK, Li X, Seeger W, Humphreys BD et al (2017) Mesenchymal stem cells in fibrotic disease. Cell Stem Cell 21(2):166\u2013177. https:\/\/doi.org\/10.1016\/j.stem.2017.07.011","journal-title":"Cell Stem Cell"},{"key":"8189_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108608","volume":"106","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Y, Liang J, Sun Z, Wu Q, Liu Y et al (2022) Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases. Int Immunopharmacol 106. https:\/\/doi.org\/10.1016\/j.intimp.2022.108608","journal-title":"Int Immunopharmacol"},{"key":"8189_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105414","volume":"167","author":"R Singh","year":"2021","unstructured":"Singh R, Kaundal RK, Zhao B, Bouchareb R, Lebeche D (2021) Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK\/STAT3 and JNK\/c-Jun signaling. Pharmacol Res 167. https:\/\/doi.org\/10.1016\/j.phrs.2020.105414","journal-title":"Pharmacol Res"},{"issue":"12","key":"8189_CR66","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/ibd.21647","volume":"17","author":"C Hofmann","year":"2011","unstructured":"Hofmann C, Chen N, Obermeier F, Paul G, Buchler C, Kopp A et al (2011) C1q\/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflamm Bowel Dis 17(12):2462\u201371. https:\/\/doi.org\/10.1002\/ibd.21647","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"8189_CR67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/BOR.0000000000001049","volume":"36","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ (2024) Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial results. Curr Opin Rheumatol 36(6):420\u2013426. https:\/\/doi.org\/10.1097\/BOR.0000000000001049","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"8189_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02592-x","volume":"23","author":"E Derrett-Smith","year":"2021","unstructured":"Derrett-Smith E, Clark KEN, Shiwen X, Abraham DJ, Hoyles RK, Lacombe O et al (2021) The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis. Arthritis Res Ther 23(1). https:\/\/doi.org\/10.1186\/s13075-021-02592-x","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"8189_CR69","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/art.43229","volume":"77","author":"L Chen","year":"2025","unstructured":"Chen L, Tan T, Chen Y, Cui F, Chen H, Zhao Y et al (2025) Dietary polyunsaturated fatty acid and the risk of rheumatoid arthritis: insights from genetic predisposition and proteomics. Arthritis Rheumatol 77(11):1475\u20131487. https:\/\/doi.org\/10.1002\/art.43229","journal-title":"Arthritis Rheumatol"},{"issue":"15","key":"8189_CR70","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1021\/acs.chemrev.1c00147","volume":"121","author":"P Paiva","year":"2021","unstructured":"Paiva P, Medina FE, Viegas M, Ferreira P, Neves RPP, Sousa JPM et al (2021) Animal fatty acid synthase: a chemical nanofactory. Chem Rev 121(15):9502\u20139553. https:\/\/doi.org\/10.1021\/acs.chemrev.1c00147","journal-title":"Chem Rev"},{"issue":"2","key":"8189_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/thoraxjnl-2011-200026","volume":"67","author":"J Milara","year":"2012","unstructured":"Milara J, Navarro R, Juan G, Peiro T, Serrano A, Ramon M et al (2012) Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax 67(2):147\u201356. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200026","journal-title":"Thorax"},{"key":"8189_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165595","author":"P Cheresh","year":"2020","unstructured":"Cheresh P, Kim SJ, Huang LS, Watanabe S, Joshi N, Williams KJN et al (2020) The sphingosine kinase 1 inhibitor, PF543, mitigates pulmonary fibrosis by reducing lung epithelial cell mtDNA damage and recruitment of fibrogenic monocytes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165595","journal-title":"Int J Mol Sci"},{"issue":"9","key":"8189_CR73","first-page":"1801","volume":"35","author":"A Abou-Raya","year":"2008","unstructured":"Abou-Raya A, Abou-Raya S, Helmii M (2008) Statins: potentially useful in therapy of systemic sclerosis-related Raynaud\u2019s phenomenon and digital ulcers. J Rheumatol 35(9):1801\u20131808","journal-title":"J Rheumatol"},{"issue":"4","key":"8189_CR74","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/art.21723","volume":"54","author":"N Louneva","year":"2006","unstructured":"Louneva N, Huaman G, Fertala J, Jimenez SA (2006) Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum 54(4):1298\u20131308. https:\/\/doi.org\/10.1002\/art.21723","journal-title":"Arthritis Rheum"},{"key":"8189_CR75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00291-2023","author":"HJ Jang","year":"2023","unstructured":"Jang HJ, Lee DY, Loloci G, Jeong J, Choi W-I (2023) Association between the use of statins and risk of interstitial lung disease\/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00291-2023","journal-title":"Eur Respir J"},{"issue":"2","key":"8189_CR76","doi-asserted-by":"publisher","first-page":"C438","DOI":"10.1152\/ajpcell.00491.2022","volume":"324","author":"M Wygrecka","year":"2023","unstructured":"Wygrecka M, Alexopoulos I, Potaczek DP, Schaefer L (2023) Diverse functions of apolipoprotein A-I in lung fibrosis. Am J Physiol Cell Physiol 324(2):C438\u2013C446. https:\/\/doi.org\/10.1152\/ajpcell.00491.2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"8189_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29901-w","volume":"8","author":"T Yamashita","year":"2018","unstructured":"Yamashita T, Lakota K, Taniguchi T, Yoshizaki A, Sato S, Hong W et al (2018) An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. Sci Rep 8(1). https:\/\/doi.org\/10.1038\/s41598-018-29901-w","journal-title":"Sci Rep"},{"issue":"8","key":"8189_CR78","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.peptides.2011.06.015","volume":"32","author":"L Otvos Jr.","year":"2011","unstructured":"Otvos L Jr., Shao WH, Vanniasinghe AS, Amon MA, Holub MC, Kovalszky I et al (2011) Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides 32(8):1567\u201374. https:\/\/doi.org\/10.1016\/j.peptides.2011.06.015","journal-title":"Peptides"},{"issue":"7","key":"8189_CR79","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1007\/s12010-025-05249-6","volume":"197","author":"J Tang","year":"2025","unstructured":"Tang J, Ruan P, Wei Z (2025) Untargeted metabolomics revealed metabolomic profile in patients with primary systemic sclerosis. Appl Biochem Biotechnol 197(7):4516\u20134527. https:\/\/doi.org\/10.1007\/s12010-025-05249-6","journal-title":"Appl Biochem Biotechnol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08189-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:15Z","timestamp":1787022915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8189"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08189-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors give their full consent for publica tion of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}